Kineta Gives $4 Million Contract For Immunotherapy Development
The growing market for immunotherapy treatments isn't just focused on cancer. Seattle biotech Kineta just landed a federal contract from the National Institutes of Health for about $4 million to develop an immunotherapy treatment which would treat a variety of infectious diseases, such as the flu, dengue fever, Ebola and others. Kineta develops drugs for chronic pain, autoimmune and...
Keytruda: The Greatest Cancer Treatment Since Forever
New Breakthrough Immunotherapy drugs are becoming even more proficient at curing a vast field of cancers and the number of ailments they can help with just keeps broadening, this includes rare and intractable tumors that have proved extremely difficult to treat with more conventional methods like chemotherapy. Researchers and scientists are saying that it will become the forefront of...
Intralymphatic Immunotherapy – The Results Are In and They Look Great
Background: Allergen-specific immunotherapy represents the only disease-modifying treatment for allergic diseases. We and others have previously demonstrated that intralymphatic immunotherapy (ILIT), a less time-consuming alternative to conventional subcutaneous immunotherapy (SCIT), is safe and effective. However, this has recently been disputed. The aim of this study was therefore to expand our previous trial, further assessing the safety and efficacy of...
Immunotherapy: Curing Cancer By Immobilizing The Immune System
https://www.youtube.com/watch?v=rGK-1qxgdJg Chronic degenerative diseases are now able to be reversed through holistic comprehensive immunotherapy. Examples of some diseases that can be reversed are Lymphoma Melanoma, Multiple Myeloma, Hodgkin’s Disease, Atherosclerosis, Arthritis, Diabetes, Candida, Lupus, Asthma, ALS, Alzheimer’s, Multiple Sclerosis, Liver Disease, Kidney Disease, Paget’s Disease, Hepatitis, Allergies, Sjoegren’s Syn., Heart Disease, Crohn’s Disease, Grave’s Disease, Thyroid Disease, Hypertension, and many...
Keytruda – Immunotherapy Drug More Effective Than Chemo
Keytruda, a cancer Immunotherapy drug, AKA Pembrolizumab was shown in a recent study to have more prolonged cancer-fighting effects than some more standard cancer treatments and have less side effects for patients with advanced melanoma cancer. After a follow-up study to the trial that led to it’s FDA approval in 2014 for treating advanced melanoma… Immunotherapy’s most popular success...
Necroptosis and Immunotherapy: Cancer’s Biggest Challenge?
Scientists at the NYU Langone Medical Center and the Laura and Isaac Perlmutter Cancer Center are researching a form of cancer treatment called necroptosis (a form of orchestrated cell death) actually can increase the rate of production of CXCL, a small protein that can spur on the growth of PDAC tumor cells. The CXCL1 protein can stimulate the creation of...
CAR-T and Immunotherapy – Cancer’s Demise…
A recent story shows that the work scientists have done on chimeric antigen receptor (CAR-T) T-cell therapy, a possible cancer cure that is a form of Immunotherapy, an alternative cancer treatment that is becoming more and more developed. The Chief Medical Officer Otis W. Brawley, was asked to give his opinion on the matter: “CAR-T is known to be an exciting...
Study Of Miracle Alternative Cancer Treatment – New Pathways Opening Up
Holger Gerhardt (VIB/KU Leuven/Cancer Research UK/ MDC/BIH Berlin) has conducted a new study with Katie Bentley's Lab (Cancer Research UK/BIDMC-Harvard Medical School) and are answering a common question asked in the field of developmental biology and tissue patterning, particularly in vascular biology, the question is: “What are the fundamental mechanisms controlling size and shape of tubular organ systems”. The...
Breakthrough Immunotherapy Drug – The End Of Cancer?
A breakthrough Immunotherapy drug has emerged in the cancer world, a medicine so powerful, it generates it's power from the immune system A new drug that harnesses the power of the immune system and instead of draining it, it actually can make the immune system dramatically stronger and increase the lifespan of the advanced head and neck cancer patients. In...
Billionaire Sean Parker Funds Immunotherapy
Silicon Valley multi-billionaire Sean Parker has funded $250 million to Immunotherapy research and development to boost survival rates of cancer. What's Immunotherapy? Plenty of professionals think it's the best cancer treatment to ever set it's bacterial foot in the door... It actually “re-wires” the immune system to fight and obliterate malignant cancer cells. The 1977 president Jimmy Carter was...
